Dianthus Therapeutics, Inc. (DNTH) stock
DNTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$86.98−2.57 (-2.87%)
Close on Nov 17, 2026Market cap $4.87BP/E –Yield 0.00%
Dianthus Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Dianthus Therapeutics's price to sales ratio was 231.9× on Oct 31, 2025, against 198.6× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Oct 31, 2025 | 231.9× | +112.6 |
| 2024 | Dec 31, 2024 | 119.3× | – |
See a number that looks wrong?